SVA logo

Sinovac Biotech (SVA) Total Expenses

Annual Total Expenses

$972.57 M
-$981.04 M-50.22%

December 1, 2023

Summary

Performance

1-Year Change

-50.22%

3-Year Change

+229.89%

5-Year Change

+427.83%

15-Year Change

+654.59%

SVA Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.05%
SVA annual total expenses is higher than 86.05% of companies in Healthcare sector

High & Low

All-time High

$1.95 B
SVA annual total expenses is currently -50.22% below its historical high of $1.95 billion

3-Year Low

$972.57 M
SVA annual total expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
SVA previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Aug 15, 2025
SVA next annual earnings announcement is scheduled for Aug 15, 2025

OtherSVAexpensesmetrics:

Annual Interest Expense

$2.26 M
SVA annual interest expense is $2.26 million

Annual Income Tax

$105.32 M
SVA annual income tax is $105.32 million

Annual Operating Expenses

$791.05 M
SVA annual total operating expenses is $791.05 million

Annual Cost Of Goods Sold

$181.52 M
SVA annual cost of goods sold is $181.52 million

Quarterly Total Expenses

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

SVA Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$130.42 M
SVA quarterly total expenses is currently at an all-time high

3-Year Low

-
SVA quarterly total expenses 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
SVA previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

Aug 15, 2025
SVA next earnings announcement is scheduled for Aug 15, 2025

OtherSVAexpensesmetrics:

Quarterly Interest Expense

-
SVA quarterly interest expense value is unknown

Quarterly Income Tax

-
SVA quarterly income tax value is unknown

Quarterly Operating Expenses

-
SVA quarterly total operating expenses value is unknown

Quarterly Cost Of Goods Sold

-
SVA quarterly cost of goods sold value is unknown

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual Total Expenses

$972.57 M
SVA annual total expenses is $972.57 million

Annual Cost Of Goods Sold

$181.52 M
SVA annual cost of goods sold is $181.52 million

Annual Operating Expenses

$791.05 M
SVA annual total operating expenses is $791.05 million

SVA Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.2%-
3 y3 years+229.9%-
5 y5 years+427.8%-

SVA Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-50.2%at low
5 y5-year-50.2%+448.9%
alltimeall time-50.2%>+9999.0%

Sinovac Biotech Total Expenses History

DateAnnualQuarterly
Dec 2023
$972.57 M(-50.2%)
-
Dec 2022
$1.95 B(+7.3%)
-
Dec 2021
$1.82 B(+517.6%)
-
Dec 2020
$294.82 M(+66.4%)
$130.42 M(+48.7%)
Sep 2020
-
$87.68 M(+67.0%)
Jun 2020
-
$52.50 M(+116.8%)
Mar 2020
-
$24.22 M(-53.6%)
Dec 2019
$177.20 M(-3.8%)
$52.24 M(+3.7%)
Sep 2019
-
$50.40 M(+17.3%)
Jun 2019
-
$42.98 M(+36.1%)
Mar 2019
-
$31.58 M(-40.3%)
Dec 2018
$184.26 M(+43.0%)
$52.93 M(+40.9%)
Sep 2018
-
$37.56 M(-38.8%)
Jun 2018
-
$61.34 M(+89.3%)
Mar 2018
-
$32.40 M(+51.9%)
Dec 2017
$128.89 M(+80.4%)
-
Dec 2016
$71.45 M(+12.2%)
$21.33 M(-4.6%)
Sep 2016
-
$22.36 M(+48.2%)
Jun 2016
-
$15.09 M(+19.1%)
Mar 2016
-
$12.67 M(-37.1%)
Dec 2015
$63.69 M(+4.5%)
$20.15 M(+11.5%)
Sep 2015
-
$18.08 M(+26.9%)
Jun 2015
-
$14.24 M(+27.0%)
Mar 2015
-
$11.22 M(-33.1%)
Dec 2014
$60.97 M(-1.2%)
$16.78 M(+3.2%)
Sep 2014
-
$16.25 M(+8.3%)
Jun 2014
-
$15.01 M(+16.1%)
Mar 2014
-
$12.93 M(-14.3%)
Dec 2013
$61.74 M(-9.4%)
$15.10 M(-20.8%)
Sep 2013
-
$19.07 M(+24.7%)
Jun 2013
-
$15.29 M(+24.8%)
Mar 2013
-
$12.26 M(-45.6%)
Dec 2012
$68.18 M
$22.52 M(+19.5%)
Sep 2012
-
$18.84 M(+48.8%)
DateAnnualQuarterly
Jun 2012
-
$12.66 M(-10.5%)
Mar 2012
-
$14.15 M(-1.4%)
Dec 2011
$53.01 M(+16.5%)
$14.35 M(-20.4%)
Sep 2011
-
$18.02 M(+43.9%)
Jun 2011
-
$12.53 M(+54.4%)
Mar 2011
-
$8.11 M(-63.7%)
Dec 2010
$45.52 M(+5.0%)
$22.37 M(+118.9%)
Sep 2010
-
$10.22 M(+33.3%)
Jun 2010
-
$7.67 M(+45.9%)
Mar 2010
-
$5.26 M(-72.7%)
Dec 2009
$43.34 M(+40.8%)
$19.27 M(+118.4%)
Sep 2009
-
$8.82 M(-5.6%)
Jun 2009
-
$9.34 M(+57.8%)
Mar 2009
-
$5.92 M(-35.1%)
Dec 2008
$30.79 M(+53.4%)
$9.13 M(+41.7%)
Sep 2008
-
$6.44 M(-32.1%)
Jun 2008
-
$9.49 M(+65.5%)
Mar 2008
-
$5.73 M(-2.9%)
Dec 2007
$20.07 M(+34.5%)
$5.91 M(-12.9%)
Sep 2007
-
$6.79 M(+84.1%)
Jun 2007
-
$3.69 M(+47.9%)
Dec 2006
$14.91 M(+11.2%)
-
Jun 2006
-
$2.49 M(-78.7%)
Dec 2005
$13.41 M(+17.6%)
$11.70 M(+1247.9%)
Sep 2005
-
$868.00 K(-71.9%)
Jun 2005
-
$3.09 M(-2.9%)
Dec 2004
$11.40 M(+238.5%)
$3.19 M(+10.9%)
Sep 2004
-
$2.87 M(+7.5%)
Jun 2004
-
$2.67 M(+78.5%)
Dec 2003
$3.37 M(+410.5%)
$1.50 M(-34.3%)
Sep 2003
-
$2.28 M
Apr 2002
$659.80 K(-9.0%)
-
Apr 2001
$725.30 K(+103.1%)
-
Apr 2000
$357.10 K(+5393.8%)
-
Apr 1999
$6500.00
-

FAQ

  • What is Sinovac Biotech annual total expenses?
  • What is the all time high annual total expenses for Sinovac Biotech?
  • What is Sinovac Biotech annual total expenses year-on-year change?
  • What is the all time high quarterly total expenses for Sinovac Biotech?

What is Sinovac Biotech annual total expenses?

The current annual total expenses of SVA is $972.57 M

What is the all time high annual total expenses for Sinovac Biotech?

Sinovac Biotech all-time high annual total expenses is $1.95 B

What is Sinovac Biotech annual total expenses year-on-year change?

Over the past year, SVA annual total expenses has changed by -$981.04 M (-50.22%)

What is the all time high quarterly total expenses for Sinovac Biotech?

Sinovac Biotech all-time high quarterly total expenses is $130.42 M